Abstract 254P
Background
Cervical cancer is the fourth most common cancer among women worldwide. In India, cervical cancer ranks second among women and there are estimated 96922 newly diagnosed cervical cancer cases and 60078 deaths. Most women present late to medical care facility due to lack of awareness. The management depends on the stage of the tumour, and includes surgery, chemotherapy and radiation. Prognosis of cervical cancer has improved recently due to novel treatment and screening approaches. Improving the quality of life is one of the most important parameters in the management of cervical cancer. Sexual function which is the principal dimension, is frequently compromised by late effects of the disease, and late treatment toxicities. This single center prospective study is one of the few studies which determine how cervical cancer and its treatment can affect the sexuality.
Methods
In this prospective study, conducted from April 2021 to April 2022, in Rajiv Gandhi Government general Hospital, Chennai, India. Post treatment 98 cervical cancer patients, 98 patients of non-gynaecological cancer and a group of 98 healthy women were recruited. Clinical features and Female Sexual Function Index (consists of desire, arousal, lubrication, orgasm, satisfaction, pain) of 3 balanced groups of women were compared.
Results
Higher rates of lymphedema were reported in cervical cancer group. About 99% of patients reported stopping their sexual activity completely during treatment; time to regular sexual activity was 9 months for the cervical cancer group, and 5 months for non-gynaecologic cancer (P =0.001). Mean vaginal length which was assessed by pelvic examination were 5.8 cm, 9.7 cm and 9.8 cm respectively for the cervical cancer group, non-gynaecologic cancer group and the control group (p=0.04). 6 parameter FSFI questionnaire, revealed worse results in the cervical cancer group (mean score was 18.3), but was statistically insignificant.
Conclusions
Sexual function, an important element for an optimal quality of life should be duly addressed throughout treatment, especially radiation. However statistically insignificant, poor sexual function indices in cervical cancer group in our study necessitates psychological component to be included in the multidisciplinary management.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
246P - Clinicoepidemiological profile and patterns of failure in carcinoma oral cavity in Indian patients: A 6-year retrospective study
Presenter: Aashita -
Session: Poster viewing 03
247TiP - Addition of induction, concurrent and maintenance durvalumab to induction and concurrent chemoradiation vs induction and concurrent chemoradiation for previously untreated locoregionally advanced nasopharyngeal carcinoma: A phase II randomised-controlled trial
Presenter: Victor Lee
Session: Poster viewing 03
248P - The use of complementary medicine in Chinese pediatric patients receiving palliative care: A multi-centre study
Presenter: Chun SIng Lam
Session: Poster viewing 03
249P - Improving quality of life and symptom burden with opioids and adjuncts in lung cancer (IQSOL study)
Presenter: Naren Gokulanathan
Session: Poster viewing 03
250P - An analysis of nutritional and psychological status of patients with advanced cancer
Presenter: Shasha Wang
Session: Poster viewing 03
251P - Is QUAD SHOT palliative cyclical hypo-fractionated radiotherapy in advanced head and neck cancer the way to go? An alternative regimen in low resource countries
Presenter: Ravi Kanodia
Session: Poster viewing 03
252P - Preferred place of death among terminally ill cancer patients: A single centre observational study from India
Presenter: Suhana Sulfiker
Session: Poster viewing 03
253P - Hemostatic radiotherapy for gastric cancer: MRI as an alternative to endoscopy for post-treatment evaluation
Presenter: Osamu Tanaka
Session: Poster viewing 03
255P - Volunteers’ role to provide quality palliative care for terminal cancer
Presenter: SAPTAPARNA JANA
Session: Poster viewing 03